Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.
In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.
Fernandez
M
M
Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
Hickman
M E
ME
Baker
C J
CJ
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000494:pharmacology*; D013290:Streptococcal Infections / Q000382:microbiology; D013291:Streptococcus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D010400:Penicillin G